fda warning letter glp-1 solution september 9 2025 Trends In FY Letters FDA Decisions Expected: October 2025
Description
The good news from clinical trials: most people who maintain tirzepatide treatment continue losing weight, albeit more slowly, even after hitting a plateau

Native human GLP-1 has a very short half-life of approximately 2 minutes due to rapid degradation primarily by the enzyme dipeptidyl peptidase-4 (DPP-4), with neutral endopeptidase (NEP) also contributing to its breakdown

At Eat Clean Bro, we understand that eating well while taking GLP-1 medications shouldnt mean sacrificing flavor or satisfaction
Whether youre on a weight loss journey, looking for a high-protein meal, or need something on the go after a gym session, meal replacement shakes can be literal lifesavers (and they're way easier than using protein powders!)
They may one day provide a safe, controlled way to deliver complex peptides without injections

Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics
